Peptide research news
New trials, mechanism findings, regulatory updates, and industry shifts. Curated weekly so you don't have to monitor a dozen sources.
·2 min read
GLP-1 Compounding Restrictions Tighten as FDA Resolves Shortages
With Semaglutide and Tirzepatide off the FDA shortage list, compounding pharmacies face new restrictions. Here's what changes for research-grade access.
SemaglutideTirzepatideRegulatory
·2 min read
First Human Trial of BPC-157 in Patellar Tendinopathy Reports Results
A small randomized human trial of injectable BPC-157 in patellar tendinopathy reports faster recovery and reduced pain vs placebo at 12 weeks. The findings are preliminary but the first of their kind.
BPC-157TrialRecovery
·2 min read
Tirzepatide Approved for Sleep Apnea in Obese Adults
The FDA expanded Tirzepatide's label to include moderate-to-severe obstructive sleep apnea, citing >50% reduction in apnea-hypopnea events vs placebo.
TirzepatideRegulatoryTrial